Abstract
Human paraoxonase-1 (PON1) is a hydrolytic enzyme related in the onset, establishment, and progression of inflammatory illnesses, including cardiovascular diseases (CVD). Therefore, the primary goal of this investigation was to determinate the influence of the PON1 gene polymorphism (Q192R) on prognostic biomarkers of CVD in women (n = 350) from San Luis Potosi, Mexico. For everyone enrolled, anthropometric, clinical, and biochemical measurements were acquired. Q192R polymorphism of the PON1 gene was assessed by real-time PCR using TaqMan probes. Also, quantification and/or calculation of suggested predictive CVD biomarkers were completed. The association between PON1(Q192R) polymorphism with clinical predictive CVD biomarkers was assessed using univariate and multivariate logistic regression models. Genotype PON1 (Q192R) frequencies were: 18%, 47% and 35% for QQ, QR, and RR, respectively. Besides, the frequency of the variant R allele was 0.58. Furthermore, robust significant associations were found between PON1 (Q192R) polymorphism with serum ADMA [OR (95% CI); 3.50 (1.20–5.00), p < 0.01]; FABP4 [2.50 (2.15–3.95), p < 0.01]; and miR-126 [1.50 (1.15–2.00), p < 0.01] levels after adjusting for probable confounders. Data found in this research strongly support the notion that proposes a crucial role of PON1 enzyme (Q192R polymorphism) as a genetic determinant in the CVD risk in Mexican women.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alegria-Torres JA, Garcia-Dominguez ML, Cruz M, Aradillas-Garcia C (2015) Q192R polymorphism of paraoxonase 1 gene associated with insulin resistance in Mexican children. Arch Med Res 46:78–83. https://doi.org/10.1016/j.arcmed.2014.12.001
Anderssohn M, Schwedhelm E, Luneburg N et al (2010) Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus. Diabetes Vasc Dis Res 7:105–118. https://doi.org/10.1177/1479164110366053
Aviram M, Vaya J (2013) Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. Curr Opin Lipidol 24:339–344. https://doi.org/10.1097/MOL.0b013e32835ffcfd
Bartel DP, Lee R, Feinbaum R (2004) MicroRNAs: genomics, biogenesis, mechanism, and function genomics: the miRNA genes. Cell 116:281–297
Boger RH (2004) Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the “l-arginine paradox” and acts as a novel cardiovascular risk factor. J Nutr 134:2842S–2847S (discussion 2853S)
Bounafaa A, Berrougui H, Ghalim N et al (2015) Association between paraoxonase 1 (PON1) polymorphisms and the risk of acute coronary syndrome in a North African population. PLoS ONE 10:e0133719. https://doi.org/10.1371/journal.pone.0133719
Bouras G, Deftereos S, Tousoulis D et al (2013) Asymmetric dimethylarginine (ADMA): a promising biomarker for cardiovascular disease? Curr Top Med Chem 13:180–200
Cardounel AJ, Cui H, Samouilov A et al (2007) Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem 282:879–887. https://doi.org/10.1074/jbc.M603606200
Cheng Y-L, Shu J-H, Hsu H-C et al (2018) High health literacy is associated with less obesity and lower Framingham risk score: sub-study of the VGH-HEALTHCARE trial. PLoS ONE 13:e0194813. https://doi.org/10.1371/journal.pone.0194813
Chow WS, Tso AWK, Xu A et al (2013) Elevated circulating adipocyte-fatty acid binding protein levels predict incident cardiovascular events in a community-based cohort: a 12-year prospective study. J Am Heart Assoc 2:e004176. https://doi.org/10.1161/JAHA.112.004176
D’Agostino RBS, Vasan RS, Pencina MJ et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117:743–753. https://doi.org/10.1161/CIRCULATIONAHA.107.699579
Dai H, Wang W, Chen R et al (2017) Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab 14:1–9. https://doi.org/10.1186/s12986-017-0206-2
Deng Z, Xiang H, Gao W (2018) Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease: a meta-analysis in the Chinese population. Herz. https://doi.org/10.1007/s00059-018-4737-8
Dhawan S, Natarajan R (2019) Epigenetics and type 2 diabetes risk. Curr Diabetes Rep 19:47. https://doi.org/10.1007/s11892-019-1168-8
Djousse L, Bartz TM, Ix JH et al (2013) Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study. Eur J Heart Fail 15:394–399. https://doi.org/10.1093/eurjhf/hfs196
Dobiasova M (2006) AIP–atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek 52:64–71
Edwards MK, Blaha MJ, Loprinzi PD (2017) Atherogenic index of plasma and triglyceride/high-density lipoprotein cholesterol ratio predict mortality risk better than individual cholesterol risk factors, among an older adult population. Mayo Clin Proc 92:680–681
El-Lebedy D, Kafoury M, Abd-El Haleem D et al (2014) Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus. J Diabetes Metab Disord 13:124. https://doi.org/10.1186/s40200-014-0125-y
Ercan M, Mungan S, Guzel I et al (2019) Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke. Adv Clin Exp Med 28:693–698. https://doi.org/10.17219/acem/78360
Ferré N, Feliu A, García-Heredia A et al (2013) Impaired paraoxonase-1 status in obese children. Relationships with insulin resistance and metabolic syndrome. Clin Biochem 46:1830–1836. https://doi.org/10.1016/j.clinbiochem.2013.08.020
Fichtlscherer S, De Rosa S, Fox H et al (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107:677–684. https://doi.org/10.1161/CIRCRESAHA.109.215566
Fortenberry GZ, Meeker JD, Sánchez BN et al (2014) Paraoxonase I polymorphisms and attention/hyperactivity in school-age children from Mexico City, Mexico. Environ Res 132:342–349. https://doi.org/10.1016/j.envres.2014.04.010
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499LP–502LP
Fukushima Y, Nakanishi M, Nonogi H et al (2011) Assessment of plasma miRNAs in congestive heart failure. Circ J 75:336–340
Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov 7:489–503. https://doi.org/10.1038/nrd2589
Furuhashi M, Ishimura S, Ota H, Miura T (2011) Lipid chaperones and metabolic inflammation. Int J Inflam 2011:642612. https://doi.org/10.4061/2011/642612
Furuhashi M, Saitoh S, Shimamoto K, Miura T (2014) Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin Med Insights Cardiol 8:23–33. https://doi.org/10.4137/CMC.S17067
Furuhashi M, Yuda S, Muranaka A et al (2018) Circulating fatty acid-binding protein 4 concentration predicts the progression of carotid atherosclerosis in a general population without medication. Circ J 82:1121–1129. https://doi.org/10.1253/circj.CJ-17-1295
Fuseya T, Furuhashi M, Yuda S et al (2014) Elevation of circulating fatty acid-binding protein 4 is independently associated with left ventricular diastolic dysfunction in a general population. Cardiovasc Diabetol 13:126. https://doi.org/10.1186/s12933-014-0126-7
Gamboa R, Zamora J, Rodríguez-Pérez JM et al (2006) Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile. Exp Mol Pathol 80:85–90. https://doi.org/10.1016/j.yexmp.2005.05.006
Garcia-Gonzalez I, Mendoza-Alcocer R, Perez-Mendoza GJ et al (2016) Distribution of genetic variants of oxidative stress metabolism genes: paraoxonase 1 (PON1) and glutathione S-transferase (GSTM1/GSTT1) in a population from Southeastern Mexico. Ann Hum Biol. https://doi.org/10.3109/03014460.2015.1126353
Gardemann A, Philipp M, Heß K et al (2000) The paraoxonase Leu–Met54 and Gln–Arg191 gene polymorphisms are not associated with the risk of coronary heart disease. Atherosclerosis 152:421–431. https://doi.org/10.1016/S0021-9150(99)00489-X
Gore MO, Luneburg N, Schwedhelm E et al (2013) Symmetrical dimethylarginine predicts mortality in the general population: observations from the Dallas heart study. Arterioscler Thromb Vasc Biol 33:2682–2688. https://doi.org/10.1161/ATVBAHA.113.301219
Hassan MA, Al-Attas OS, Hussain T et al (2013) The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects. Mol Cell Biochem 380:121–128. https://doi.org/10.1007/s11010-013-1665-z
Hasselwander O, Savage DA, Mcmaster D et al (1999) Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 56:289–298. https://doi.org/10.1046/j.1523-1755.1999.00521.x
Helbecque N, Cottel D, Meirhaeghe A et al (1999) Paraoxonase (Gln192-Arg) polymorphism in French type 2 diabetics. Atherosclerosis 147:415–416
Humbert R, Adler DA, Disteche CM et al (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 3:73–76. https://doi.org/10.1038/ng0193-73
Imai Y, Morita H, Kurihara H et al (2000) Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases. Atherosclerosis 149:435–442
Jellinger PS, Handelsman Y, Rosenblit PD et al (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract 23:1–87. https://doi.org/10.4158/EP171764.APPGL
Karagianni P, Tzioufas AG (2019) Epigenetic perspectives on systemic autoimmune disease. J Autoimmun. https://doi.org/10.1016/j.jaut.2019.102315
Khoja SO, El Miedany Y, Iyer AP et al (2017) Association of paraoxonase 1 polymorphism and serum 25-hydroxyvitamin D with the risk of cardiovascular disease in patients with rheumatoid arthritis. Clin Lab 63:1841–1849
Kim Y-K, Yeo J, Kim B et al (2012) Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell 46:893–895
Kirschner MB, van Zandwijk N, Reid G (2013) Cell-free microRNAs: potential biomarkers in need of standardized reporting. Front Genet 4:56. https://doi.org/10.3389/fgene.2013.00056
Kontaraki JE, Marketou ME, Zacharis EA et al (2014) MicroRNA-9 and microRNA-126 expression levels in patients with essential hypertension: potential markers of target-organ damage. J Am Soc Hypertens 8:368–375. https://doi.org/10.1016/j.jash.2014.03.324
Konya H, Miuchi M, Satani K et al (2015) Asymmetric dimethylarginine, a biomarker of cardiovascular complications in diabetes mellitus. World J Exp Med 5:110–119. https://doi.org/10.5493/wjem.v5.i2.110
Leus FR, Wittekoek ME, Prins J et al (2000) Paraoxonase gene polymorphisms are associated with carotid arterial wall thickness in subjects with familial hypercholesterolemia. Atherosclerosis 149:371–377
Liu G, Ding M, Chiuve SE et al (2016) Plasma levels of fatty acid-binding protein 4, retinol-binding protein 4, high-molecular-weight adiponectin, and cardiovascular mortality among men with type 2 diabetes: a 22-year prospective study. Arterioscler Thromb Vasc Biol 36:2259–2267. https://doi.org/10.1161/ATVBAHA.116.308320
Liu X, Xu X, Shang R, Chen Y (2018) Asymmetric dimethylarginine (ADMA) as an important risk factor for the increased cardiovascular diseases and heart failure in chronic kidney disease. Nitric Oxide Biol Chem 78:113–120. https://doi.org/10.1016/j.niox.2018.06.004
López-Flores I, Lacasaña M, Blanco-Muñoz J et al (2009) Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides. Toxicol Lett 188:84–90. https://doi.org/10.1016/j.toxlet.2009.03.010
Mackness M, Mackness B (2015) Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles. Gene 567:12–21. https://doi.org/10.1016/j.gene.2015.04.088
Mackness MI, Arrol S, Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152–154
Mackness B, Davies GK, Turkie W et al (2001) Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21:1451–1457
Martinez-Salazar MF, Almenares-Lopez D, Garcia-Jimenez S et al (2011) Relationship between the paraoxonase (PON1) L55M and Q192R polymorphisms and obesity in a Mexican population: a pilot study. Genes Nutr 6:361–368. https://doi.org/10.1007/s12263-011-0215-0
Meinitzer A, Seelhorst U, Wellnitz B et al (2007) Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 53:273–283. https://doi.org/10.1373/clinchem.2006.076711
Meinitzer A, Kielstein JT, Pilz S et al (2011) Symmetrical and asymmetrical dimethylarginine as predictors for mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health study. Clin Chem 57:112–121. https://doi.org/10.1373/clinchem.2010.150854
Moreno-Banda G, Blanco-Muñoz J, Lacasaña M et al (2009) Maternal exposure to floricultural work during pregnancy, PON1 Q192R polymorphisms and the risk of low birth weight. Sci Total Environ 407:5478–5485. https://doi.org/10.1016/j.scitotenv.2009.06.033
Morgado-Pascual JL, Marchant V, Rodrigues-Diez R et al (2018) Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology. Mediat Inflamm 2018:2931049. https://doi.org/10.1155/2018/2931049
Najafi M, Gohari LH, Firoozrai M (2009) Paraoxonase 1 gene promoter polymorphisms are associated with the extent of stenosis in coronary arteries. Thromb Res 123:503–510. https://doi.org/10.1016/j.thromres.2008.03.004
Ochoa-Martinez AC, Ruiz-Vera T, Orta-Garcia ST et al (2017a) Association between Q192R paraoxonase 1 polymorphism and serumadipocyte-fatty acid binding protein (FABP4) levels in Mexican women. Ann Hum Biol 44:389–391. https://doi.org/10.1080/03014460.2016.1245785
Ochoa-Martinez AC, Ruiz-Vera T, Pruneda-Alvarez LG et al (2017b) Serum adipocyte-fatty acid binding protein (FABP4) levels in women from Mexico exposed to polycyclic aromatic hydrocarbons (PAHs). Environ Sci Pollut Res Int 24:1862–1870. https://doi.org/10.1007/s11356-016-7971-8
Ochoa-Martinez AC, Cardona-Lozano ED, Carrizales-Yanez L, Perez-Maldonado IN (2018) Serum concentrations of new predictive cardiovascular disease biomarkers in Mexican women exposed to lead. Arch Environ Contam Toxicol 74:248–258. https://doi.org/10.1007/s00244-017-0491-9
Ochoa-Martínez ÁC, Ruíz-Vera T, Almendarez-Reyna CI et al (2017) Influence on serum asymmetric dimethylarginine (ADMA) concentrations of human paraoxonase 1 polymorphism (Q192R) and exposure to polycyclic aromatic hydrocarbons (PAHs) in Mexican women, a gene-environment interaction. Chemosphere 186:770–779. https://doi.org/10.1016/j.chemosphere.2017.08.055
Pala L, Monami M, Ciani S et al (2012) Adipokines as possible new predictors of cardiovascular diseases: a case control study. J Nutr Metab 2012:253428. https://doi.org/10.1155/2012/253428
Peralta-Arrieta I, Armas-Lopez L, Zuniga J, Avila-Moreno F (2019) Epigenetics in non-small cell lung carcinomas. Salud Publica Mex 61:318–328
Pérez-Herrera N, May-Pech C, Hernández-Ochoa I et al (2008a) PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy. Exp Mol Pathol 85:129–134. https://doi.org/10.1016/j.yexmp.2008.05.003
Pérez-Herrera N, Polanco-Minaya H, Salazar-Arredondo E et al (2008b) PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico. Toxicol Appl Pharmacol 230:261–268. https://doi.org/10.1016/j.taap.2008.02.021
Perez-Vazquez MS, Ochoa-Martinez AC, RuIz-Vera T et al (2017) Evaluation of epigenetic alterations (mir-126 and mir-155 expression levels) in Mexican children exposed to inorganic arsenic via drinking water. Environ Sci Pollut Res Int 24:28036–28045. https://doi.org/10.1007/s11356-017-0367-6
Pruneda-Alvarez LG, Perez-Vazquez FJ, Ruiz-Vera T et al (2016a) Urinary 1-hydroxypyrene concentration as an exposure biomarker to polycyclic aromatic hydrocarbons (PAHs) in Mexican women from different hot spot scenarios and health risk assessment. Environ Sci Pollut Res Int 23:6816–6825. https://doi.org/10.1007/s11356-015-5918-0
Pruneda-Alvarez LG, Ruíz-Vera T, Ochoa-Martínez AC et al (2016b) Plasma asymmetric dimethylarginine (ADMA) levels in Mexican women exposed to polycyclic aromatic hydrocarbons (PAHs): a preliminary study. Sci Total Environ 572:1195–1202. https://doi.org/10.1016/j.scitotenv.2016.08.037
Pruneda-Alvarez LG, Ruíz-Vera T, Ochoa-Martínez AC, Pérez-Maldonado IN (2017) Urinary trans-trans muconic acid (exposure biomarker to benzene) and hippuric acid (exposure biomarker to toluene) concentrations in Mexican women living in high-risk scenarios of air pollution. Arch Environ Occup Heal 72:351–358. https://doi.org/10.1080/19338244.2016.1272539
Rodriguez-Calvo R, Girona J, Alegret JM et al (2017) Role of the fatty acid binding protein 4 in heart failure and cardiovascular disease. J Endocrinol. https://doi.org/10.1530/JOE-17-0031
Ruiz-Vera T, Pruneda-Álvarez LG, Ochoa-Martínez ÁC et al (2015) Assessment of vascular function in Mexican women exposed to polycyclic aromatic hydrocarbons from wood smoke. Environ Toxicol Pharmacol 40:423–429. https://doi.org/10.1016/j.etap.2015.07.014
Ruiz-Vera T, Ochoa-Martinez AC, Pruneda-Alvarez LG et al (2019a) Exposure to biomass smoke is associated with an increased expression of circulating miRNA-126 and miRNA-155 in Mexican women: a pilot study. Drug Chem Toxicol 42:335–342. https://doi.org/10.1080/01480545.2018.1526181
Ruiz-Vera T, Ochoa-Martinez AC, Pruneda-Alvarez LG et al (2019b) Expression levels of circulating microRNAs-126, -155, and -145 in Mexican women exposed to polycyclic aromatic hydrocarbons through biomass fuel use. Environ Mol Mutagen. https://doi.org/10.1002/em.22273
Ruiz-Vera T, Ochoa-Martinez AC, Zarazua S et al (2019c) Circulating miRNA-126, -145 and -155 levels in Mexican women exposed to inorganic arsenic via drinking water. Environ Toxicol Pharmacol 67:79–86. https://doi.org/10.1016/j.etap.2019.02.004
Salonen JT, Malin R, Tuomainen TP et al (1999) Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study. BMJ 319:487–489 discussion 490
Schlesinger S, Sonntag SR, Lieb W, Maas R (2016) Asymmetric and symmetric dimethylarginine as risk markers for total mortality and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. PLoS ONE 11:e0165811. https://doi.org/10.1371/journal.pone.0165811
Schnabel R, Blankenberg S, Lubos E et al (2005) Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study. Circ Res 97:e53–e59. https://doi.org/10.1161/01.RES.0000181286.44222.61
Shahsavari G, Cheraghi M, Maleki A, Ahmadvand H (2017) Paraoxonase 1 activity, lipid profile, and atherogenic indexes status in coronary heart disease. Rep Biochem Mol Biol 6:1–7
Shunmoogam N, Naidoo P, Chilton R (2018) Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance. Vasc Health Risk Manag 14:137–143. https://doi.org/10.2147/VHRM.S165173
Skuratovskaia D, Vulf M, Komar A et al (2019) Promising directions in atherosclerosis treatment based on epigenetic regulation using MicroRNAs and long noncoding RNAs. Biomolecules. https://doi.org/10.3390/biom9060226
Soran H, Schofield JD, Durrington PN (2015a) Antioxidant properties of HDL. Front Pharmacol 6:222. https://doi.org/10.3389/fphar.2015.00222
Soran H, Schofield JD, Liu Y, Durrington PN (2015b) How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. Curr Opin Lipidol 26:247–256. https://doi.org/10.1097/MOL.0000000000000194
Tammen SA, Friso S, Choi S-W (2013) Epigenetics: the link between nature and nurture. Mol Asp Med 34:753–764. https://doi.org/10.1016/j.mam.2012.07.018
Valkonen VP, Paiva H, Salonen JT et al (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358:2127–2128. https://doi.org/10.1016/s0140-6736(01)07184-7
Veiga L, Silva-Nunes J, Melao A et al (2011) Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women. Eur J Endocrinol 164:213–218. https://doi.org/10.1530/EJE-10-0825
Voelter-Mahlknecht S (2016) Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clin Epigenetics 8:4. https://doi.org/10.1186/s13148-016-0170-0
Vrijens K, Bollati V, Nawrot TS (2015) MicroRNAs as potential signatures of environmental exposure or effect: a systematic review. Environ Health Perspect 123:399–411. https://doi.org/10.1289/ehp.1408459
Wang X, Fan Z, Huang J et al (2003) Extensive association analysis between polymorphisms of PON gene cluster with coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 23:328–334
WHO (2016) WHO | Household (Indoor) Air Pollution
WHO. World Heart Federation. World Stroke Organization (2011) Global Atlas on Cardiovascular disease prevention and control. Publ World Heal Organ Collab World Hear Fed World Hear Fed World Stroke Organ 155:120
Wojciechowska A, Braniewska A, Kozar-Kaminska K (2017) MicroRNA in cardiovascular biology and disease. Adv Clin Exp Med 26:865–874
Woodward L, Akoumianakis I, Antoniades C (2017) Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease. Br J Pharmacol 174:4007–4020. https://doi.org/10.1111/bph.13619
World Health Organization (2014) Global status report on noncommunicable diseases 2014. World Health 176
Wu H, Zhang J (2018) miR-126 in peripheral blood mononuclear cells negatively correlates with risk and severity and is associated with inflammatory cytokines as well as intercellular adhesion molecule-1 in patients with coronary artery disease. Cardiology 139:110–118. https://doi.org/10.1159/000484236
Xuan C, Tian Q-W, Li H et al (2016) Levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, and risk of coronary artery disease: a meta-analysis based on 4713 participants. Eur J Prev Cardiol 23:502–510. https://doi.org/10.1177/2047487315586094
Yang Y, Yu T, Jiang S et al (2017) miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204. Expert Opin Ther Pat 27:1021–1029. https://doi.org/10.1080/13543776.2017.1344217
Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810–817. https://doi.org/10.1161/CIRCRESAHA.110.226357
Zampetaki A, Willeit P, Tilling L et al (2012) Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 60:290–299. https://doi.org/10.1016/j.jacc.2012.03.056
Zhang Z, Ou J, Cai P et al (2018) Association between the PON1 Q192R polymorphism and coronary heart disease in Chinese: a meta-analysis. Medicine 97:e11151. https://doi.org/10.1097/MD.0000000000011151
Zhou S, Zhu Q, Li X et al (2017) Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis. Sci Rep 7:44692. https://doi.org/10.1038/srep44692
Acknowledgements
This work was financed by a grant from: (1) Consejo Nacional de Ciencia y Tecnología, México. Proyectos de Desarrollo Científico para Atender Problemas Nacionales 2015. PDCPN2015-1558. (2) Programa Para el Desarrollo Profesional Docente (PRODEP), Secretaria de Educación Pública (SEP). Apoyo a la reincorporación de ex-becarios 2018. No. De proyecto; UAZ-EXB-400, 511-6/2019.-1007.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ochoa-Martínez, Á.C., Orta-García, S.T., Varela-Silva, J.A. et al. Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women. Biochem Genet 58, 801–820 (2020). https://doi.org/10.1007/s10528-020-09975-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-020-09975-w